NLS Pharmaceutics AG
NASDAQ:NLSP
NLS Pharmaceutics AG
NASDAQ:NLSP
Price:
0.1415 USD
2.09%
Market Closed
Updated:
May 10, 2024
NLS Pharmaceutics AG
Net Income (Common)
|
NLS Pharmaceutics AG
Net Income (Common) Peer Comparison
Comparables:
NOVN
ROG
S
SDZ
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Net Income (Common)
-$16.5m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Novartis AG
SIX:NOVN
|
Net Income (Common)
$17.5B
|
CAGR 3-Years
30%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
Roche Holding AG
SIX:ROG
|
Net Income (Common)
CHf11.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Net Income (Common)
$848m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is NLS Pharmaceutics AG's Net Income (Common)?
Net Income (Common)
-16.5m
USD
-16.5m
USD
Based on the financial report for Dec 31, 2022, NLS Pharmaceutics AG's Net Income (Common) amounts to -16.5m USD.
What is NLS Pharmaceutics AG's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-20%
-20%
Over the last year, the Net Income (Common) growth was -38%. The average annual Net Income (Common) growth rates for NLS Pharmaceutics AG have been -45% over the past three years , -20% over the past five years .
You don't have any saved screeners yet
